Recent Quotes (30 days)

You have no recent quotes
chg | %

Aurinia Pharmaceuticals Inc  

(Public, TSE:AUP)   Watch this stock  
Find more results for TSE:ISA
4.72
-0.24 (-4.84%)
Apr 20 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 4.57 - 4.95
52 week 2.75 - 7.00
Open 4.91
Vol / Avg. 15,954.00/7,256.00
Mkt cap 150.95M
P/E     -
Div/yield     -
EPS -0.74
Shares 31.82M
Beta 2.20
Inst. own     -
Mar 30, 2015
Q4 2014 Aurinia Pharmaceuticals Inc Earnings Release
Mar 2, 2015
Aurinia Pharmaceuticals Inc at Cowen Health Care Conference
Feb 12, 2015
Aurinia Pharmaceuticals Inc at Leerink Global Healthcare Conference
Feb 10, 2015
Aurinia Pharmaceuticals Inc at Biotechnology Industry Organization CEO & Investor Conference
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -7233.82% -5988.13%
Operating margin -7076.47% -6577.34%
EBITD margin - -5669.42%
Return on average assets -36.28% -44.07%
Return on average equity -41.79% -56.99%
Employees 26 -
CDP Score - -

Address

1203-4464 Markham St
VICTORIA, BC V8Z 7X8
Canada
+1-250-7084272 (Phone)
+1-250-7442498 (Fax)

Website links

Description

Aurinia Pharmaceuticals Inc., formerly Isotechnika Pharma Inc, is a Canada-based biopharmaceutical company focused on the development of its therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis. Its lead drug, voclosporin, is an immunosuppressant effective in indications, such as prevention of rejection in renal transplantation and for lupus nephritis (LN). LN is an inflammation of the kidneys, that if inadequately treated can lead to end-stage renal disease, making LN a serious and potentially life-threatening condition.

Officers and directors

Richard M. Glickman Executive Chairman of the Board
Age: 56
Stephen W. Zaruby President, Chief Executive Officer
Age: 49
Dennis Bourgeault Chief Financial Officer, Corporate Secretary
Michael R. Martin Chief Operating Officer
Robert Huizinga Vice President - Clinical Affairs
Charles A. Rowland Jr. Director
Age: 56
Prakash Gowd Independent Director
Age: 48
Donald W. Wyatt Independent Director
Age: 45